The Report Cube which is one of the leading market research company in UAE expects the Europe Point-of-Care Testing (POCT) Market to grow at a CAGR of around 9.04% through 2032, as highlighted in their latest research report. The study provides an in-depth analysis of the emerging trends shaping the Europe Point-of-Care Testing (POCT) Market and offers detailed forecasts for its potential growth during 2026–2032. The report also presents a comprehensive assessment of the competitive landscape, including profiles of leading players, their performance metrics, and recent strategic developments. Additionally, it explores the key market drivers, challenges, opportunities, and provides insights into historical and future revenue trends at the global, regional, and country levels.
Europe Point-of-Care Testing (POCT) Market Overview:
Market Size (2025): USD 8.52 Billion
Market Size (2032): USD 14.32 Billion
CAGR (2026–2032): 9.04%
Top Companies in Europe Point-of-Care Testing (POCT) Market: Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc.
Request a Free Sample PDF of This Report - https://www.thereportcubes.com/request-sample/europe-point-of-care-testing-market
US LiDAR Industry Recent News and Developments:
Abbott Laboratories introduced its next-generation i-STAT Alinity platform in Europe, offering advanced blood analysis diagnostics with quicker result delivery & connectivity for improved clinical decisions.
F. Hoffmann-La Roche Ltd. launched its Cobas pulse system for hospital settings, incorporating smartphone-style interface technology with lab-grade diagnostic precision, further linking the gap between POCT & central labs.
BioMerieux SA extended its BioFire FilmArray platform portfolio in Europe to include additional respiratory & gastrointestinal panels to reinforce infectious disease management.
Key Growth Drivers of the Europe Point-of-Care Testing (POCT) Market:
Driver: Rising Demand for Rapid Diagnostics to Drive the Industry
The imperative requirement for faster diagnosis & treatment, specifically in emergency departments & remote care settings, is a key driver. POCT devices allow clinicians to make real-time decisions, decreasing hospital stay durations & enhancing patient outcomes. Also, the increasing popularity of diabetes, cardiovascular conditions, and infectious diseases further solidifies the market demand.
Europe Point-of-Care Testing (POCT) Market Segmentation
The European point-of-care (POC) diagnostics market is segmented by technology, end user, platform, application, and country. By technology, PCR-based and genetic sequencing-based diagnostics are leading due to high accuracy, while microarray and hybridization-based methods are gaining adoption in specialized labs. End users include decentralized labs, hospitals, homecare, and assisted living facilities, reflecting widespread demand for rapid diagnostics. Platform-wise, lateral flow assays, immunoassays, and molecular diagnostics dominate, supporting diverse clinical needs. Key applications cover blood glucose monitoring, infectious diseases, cardiac and coagulation monitoring, and non-invasive vital sign assessments. Geographically, the UK, Germany, France, Italy, Spain, and Switzerland are leading markets, with other European nations showing steady growth in POC adoption.
- Market Share, By Technology
- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
- Market Share, By End User
- Decentralized Labs
- Hospitals
- Homecare
- Assisted Living Healthcare Facilities
- Other
- Market Share, By Platform
- Lateral Flow Assays/Immunochromatography Tests
- Immunoassays
- Dipsticks
- Molecular Diagnostics
- Clinical Chemistry Assays
- Microfluidics
- Hematology
- Others
Gain complete insights into market segmentation, key trends, and forecasts by accessing the full report - https://www.thereportcubes.com/request-sample/europe-point-of-care-testing-market
· Market Share, By Application
- Blood Glucose
- Infectious Diseases
- Vital Sign Monitoring
- Cardiac Monitoring
- Coagulation
- Haematology
- Non- Invasive Spo2 Monitoring
- Blood Transfusion
- Non- Invasive Pco2 Monitoring
- Whole Blood Analysis
- Others
- Market Share, By Country
- The UK
- Germany
- France
- Italy
- Spain
- Russia
- The Netherlands
- Switzerland
- Others
Note:
If you need additional data points, insights, or specific information not covered within the current scope of this report, we are pleased to offer customized research support. Through our tailored customization service, we can gather and deliver the exact information you require aligned with your unique objectives and business needs. Simply share your requirements, and our team will ensure the report is updated accordingly to meet your expectations with precision and accuracy.
Contact Us - https://www.thereportcubes.com/contact-us
About The Report Cube
The Report Cube is a leading provider of market research and business intelligence solutions in UAE, dedicated to helping organizations make smarter, data-driven decisions. With a comprehensive library of over 900,000 industry reports covering 800+ sectors worldwide, the company delivers precise insights, actionable forecasts, and strategic recommendations tailored to client objectives.
Backed by a team of 1,700+ experienced analysts and researchers, The Report Cube empowers businesses with the knowledge they need to navigate evolving markets, identify opportunities, and sustain growth in an ever-changing global landscape.
The company specializes in syndicated research, customized studies, competitive analysis, company profiling, and industry forecasting, serving clients across industries including energy, technology, healthcare, manufacturing, and more.
For more information, visit www.thereportcubes.com.
Burjuman Business Tower, Burjuman, Dubai
